ProSys is a leading provider of isolator technology and sampling systems to the bio-pharmaceutical market We design and manufacture EtO - ‘Engineered to Order’ - isolators for aseptic processing in ISO5 environments and for the management of highly potent compound handling to OEB5 & 6 levels. We also design and build liquid, gas and powder sampling systems for industry including toxic applications and for high pressure, viscous and low volume sampling. A focus on 'Customer Intimacy', design flexibility, equipment quality and delivery assurance has been the corner-stone of our growth and development since we were founded in 1997. We operate globally with local in-market technical and after sales service support to serve our client base drawn from the Clinical, R&D, Manufacturing and Consultancy sectors
| Website | https://www.prosys.com |
| Revenue | $65.6 million |
| Employees | 86 (0 on RocketReach) |
| Founded | 1997 |
| Industry | Mechanical or Industrial Engineering |
| Keywords | Isolator Technology, Aseptic Processing, Sampling Systems, Engineered To Order, Contamination Control, Cleanroom Technology, Bioprocessing, Pharmaceutical Manufacturing, Process Automation, Sterile Production, Aseptic Filling |
| Competitors | Cisco, Dell, Hewlett Packard Enterprise, NVIDIA, VMware Tanzu Labs, Juniper Networks, Arista Networks, Extreme Networks, NETGEAR, MikroTik +46 more (view full list) |
Looking for a particular ProSys Group employee's phone or email?
ProSys Group Questions
The ProSys Group annual revenue was $65.6 million in 2026.
